Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel Free BCYC Stock Alerts

Bicycle Therapeutics (BCYC) Short Interest Ratio & Short Volume

Bicycle Therapeutics logo
$4.41 +0.23 (+5.50%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$4.40 0.00 (-0.11%)
As of 07/10/2026 05:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Bicycle Therapeutics Short Interest Overview

As of June 30, 2026, Bicycle Therapeutics (BCYC) had a short interest of 2.88 million shares sold short, representing 5.36% of the public float. This marks a 2.06% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.8, meaning it would take 4.8 days of the average trading volume of 614,555 shares to cover all short positions.

Current Short Interest
2,883,802 shares
Previous Short Interest
2,825,596 shares
Change Vs. Previous Month
2.06%
Dollar Volume Sold Short
$12.23 million
Short Interest Ratio
4.8 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
69,810,000 shares
Short Percent of Float
5.36%
Today's Trading Volume
804,201 shares
Average Trading Volume
614,555 shares
Today's Volume Vs. Average
131%
Short Selling Bicycle Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Bicycle Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BCYC Short Interest Over Time

BCYC Days to Cover Over Time

BCYC Percentage of Float Shorted Over Time

Bicycle Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20262,883,802 shares $12.23 million +2.1%5.4%4.75 $4.24
6/15/20262,825,596 shares $11.73 million -1.3%5.2%4.36 $4.15
5/29/20262,861,415 shares $13.42 million +5.9%4.5%10.81 $4.69
5/15/20262,701,708 shares $12.02 million -7.7%5.0%7.57 $4.45
4/30/20262,926,371 shares $13.81 million +11.1%4.6%7.88 $4.72
4/15/20262,635,218 shares $13.91 million +14.9%4.9%5.93 $5.28
3/31/20262,292,727 shares $10.64 million +4.6%4.3%3.29 $4.64
3/13/20262,191,382 shares $10.47 million +3.6%3.5%6.43 $4.78
2/27/20262,115,375 shares $12.12 million -0.9%3.9%5.99 $5.73
2/13/20262,135,351 shares $11.19 million +7.4%3.3%3.98 $5.24
1/30/20261,988,977 shares $12.77 million +1.7%3.1%8.63 $6.42
1/15/20261,954,971 shares $12.65 million -1.9%3.1%7.33 $6.47
12/31/20251,993,719 shares $14.12 million -0.3%3.1%8.84 $7.08
12/15/20251,999,025 shares $14.65 million +16.7%3.1%7.69 $7.33
11/28/20251,713,257 shares $12.85 million +3.3%2.7%5.22 $7.50
11/14/20251,659,385 shares $10.75 million +10.8%2.6%3.78 $6.48
10/31/20251,498,320 shares $12.09 million -2.5%2.4%5.75 $8.07
10/15/20251,540,000 shares $12.92 million -0.7%2.4%5.6 $8.39
9/30/20251,550,000 shares $12.00 million +6.2%N/A5.6 $7.74
9/15/20251,460,000 shares $10.02 million -8.2%N/A5.2 $6.86
8/31/20251,590,000 shares $11.73 million -3.6%3.0%5.8 $7.38
8/15/20251,650,000 shares $12.28 million -0.6%N/A6 $7.44
7/31/20251,660,000 shares $14.14 million -23.5%3.1%5.8 $8.52
7/15/20252,170,000 shares $16.67 million -16.5%N/A6.8 $7.68
6/30/20252,600,000 shares $18.07 million +4.8%4.9%7.6 $6.95
6/15/20252,480,000 shares $20.76 million -28.1%4.6%7.1 $8.37
5/31/20253,450,000 shares $28.36 million +3.6%5.5%9.7 $8.22
5/15/20253,330,000 shares $27.04 million +8.8%5.3%9.2 $8.12
4/30/20253,060,000 shares $26.19 million -2.2%N/A8.6 $8.56
4/15/20253,130,000 shares $24.38 million -27.2%5.0%9 $7.79
3/31/20254,300,000 shares $36.51 million -2.3%6.8%13 $8.49
3/15/20254,400,000 shares $42.64 million +4.3%7.0%13.2 $9.69
2/28/20254,220,000 shares $46.29 million -0.9%6.7%8.7 $10.97
2/15/20254,260,000 shares $53.46 million -0.9%6.7%8.3 $12.55
1/31/20254,300,000 shares $57.58 million +0.5%N/A7.9 $13.39
1/15/20254,280,000 shares $62.27 million +8.6%N/A7.7 $14.55
12/31/20243,940,000 shares $55.16 million +14.9%N/A6.7 $14.00
12/15/20243,430,000 shares $47.37 million +1.2%N/A5.8 $13.81
11/30/20243,390,000 shares $69.16 million -3.7%N/A7.2 $20.40
11/15/20243,520,000 shares $76.70 million +7.7%N/A7.8 $21.79
Ray Dalio: Buy Gold. Get Paid. (Ad)

Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and crypto as U.S. debt continues to climb and fiat currencies lose purchasing power. A little-known $15 fund is already converting gold's momentum into monthly income - as much as $1,152 per month. No gold bars, no mining stocks, just consistent payouts.tc pixel

See how to follow Dalio's gold strategy and collect monthly income
10/31/20243,270,000 shares $76.67 million +12.0%N/A8.1 $23.45
10/15/20242,920,000 shares $79.10 million +10.2%N/A7.6 $27.09
9/30/20242,650,000 shares $59.97 million +12.3%N/A8.1 $22.63
9/15/20242,360,000 shares $63.77 million +12.4%N/A8.1 $27.02
8/31/20242,100,000 shares $45.15 million -4.6%N/A8.3 $21.50
8/15/20242,200,000 shares $49.98 million +6.3%N/A7.7 $22.72
7/31/20242,070,000 shares $50.32 million -23.1%N/A7.3 $24.31
7/15/20242,690,000 shares $60.79 million -4.3%N/A9.3 $22.60
6/30/20242,810,000 shares $56.87 million +1.1%N/A8.8 $20.24
6/15/20242,780,000 shares $64.22 million +6.1%N/A7.6 $23.10
5/31/20242,620,000 shares $58.14 million -9.3%N/A6.9 $22.19
5/15/20242,890,000 shares $64.62 million +3.6%N/A7.5 $22.36
4/30/20242,790,000 shares $65.43 million -5.7%N/A7 $23.45
4/15/20242,960,000 shares $64.59 million +16.5%N/A7.4 $21.82
3/31/20242,540,000 shares $63.25 million -0.8%N/A6.6 $24.90
3/15/20242,560,000 shares $60.83 million -7.3%N/A7.1 $23.76
2/29/20242,760,000 shares $69.25 million -18.6%N/A6.1 $25.09
2/15/20243,390,000 shares $74.89 million -10.3%N/A7.2 $22.09
1/31/20243,780,000 shares $65.96 million -1.8%N/A7.9 $17.45
1/15/20243,850,000 shares $71.03 million -0.5%N/A7.1 $18.45
12/31/20233,870,000 shares $69.97 million -4.2%N/A7 $18.08
12/15/20234,040,000 shares $70.74 million -2.7%N/A7.3 $17.51
11/30/20234,150,000 shares $59.76 million +3.8%N/A8.5 $14.40
11/15/20234,000,000 shares $61.56 million -8.5%N/A9.2 $15.39
10/31/20234,370,000 shares $65.77 million -1.4%N/A10.8 $15.05
10/15/20234,430,000 shares $89.57 million -7.3%N/A12.7 $20.22
9/30/20234,780,000 shares $96.03 million +5.5%N/A14.1 $20.09
9/15/20234,530,000 shares $94.41 million +3.7%N/A14.4 $20.84
8/31/20234,370,000 shares $95.00 million +7.6%N/A16.7 $21.74
8/15/20234,060,000 shares $88.35 million +8.6%N/A17 $21.76
7/31/20233,740,000 shares $92.00 million -13.2%N/A16.7 $24.60
7/15/20234,310,000 shares $112.97 million +1.7%N/A21.7 $26.21
6/30/20234,240,000 shares $108.20 million +1.7%N/A23.8 $25.52
6/15/20234,170,000 shares $110.96 million -0.7%N/A17.9 $26.61
5/31/20234,200,000 shares $100.72 million -0.9%N/A15.5 $23.98
5/15/20234,240,000 shares $101.21 million +15.2%N/A14.7 $23.87
4/30/20233,680,000 shares $72.72 million +5.1%N/A10.8 $19.76
4/15/20233,500,000 shares $66.33 million +0.3%N/A10 $18.95
3/31/20233,490,000 shares $74.23 million +14.4%N/A10 $21.27
3/15/20233,050,000 shares $65.54 million -2.9%N/A10.3 $21.49
2/28/20233,140,000 shares $71.37 million +53.9%N/A10.8 $22.73
2/15/20232,040,000 shares $50.29 million +8.5%N/A7.2 $24.65
1/31/20231,880,000 shares $51.93 million +0.5%N/A7.6 $27.62
1/15/20231,870,000 shares $52.04 million -5.6%N/A8.2 $27.83
12/30/20221,980,000 shares $58.61 million -10.4%N/A8.5 $29.60
12/15/20222,210,000 shares $69.11 million -14.3%N/A9.6 $31.27
11/30/20222,580,000 shares $74.72 million +1.2%N/A10.9 $28.96
11/15/20222,550,000 shares $72.01 million -8.6%N/A11.7 $28.24
10/31/20222,790,000 shares $69.05 million -14.9%N/A12.8 $24.75
10/15/20223,280,000 shares $71.80 million +7.2%N/A15 $21.89
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
9/30/20223,060,000 shares $71.18 million +5.2%N/A13.9 $23.26
9/15/20222,910,000 shares $71.53 million +1.4%N/A11 $24.58
8/31/20222,870,000 shares $75.91 million No ChangeN/A9.4 $26.45
8/15/20222,870,000 shares $75.77 million -1.4%N/A8.8 $26.40
7/31/20222,910,000 shares $68.56 million -2.0%N/A7.5 $23.56
7/15/20222,970,000 shares $62.31 million +10.8%N/A6.9 $20.98
6/30/20222,680,000 shares $44.97 million +18.6%N/A4.1 $16.78
6/15/20222,260,000 shares $30.49 million -6.2%N/A3.6 $13.49
5/31/20222,410,000 shares $38.54 million -2.4%N/A4 $15.99
5/15/20222,470,000 shares $42.85 million +27.3%N/A4.3 $17.35
4/30/20221,940,000 shares $45.55 million +10.9%N/A3.8 $23.48
4/15/20221,750,000 shares $42.02 million +230.0%N/A3.9 $24.01
3/31/2022530,300 shares $23.27 million +16.2%N/A1.8 $43.88
3/15/2022456,300 shares $19.20 million -3.8%N/A2.1 $42.07
2/28/2022474,100 shares $22.52 million -1.6%N/A2.2 $47.50
2/15/2022481,700 shares $23.16 million -8.3%N/A2.3 $48.08
1/31/2022525,500 shares $25.66 million +40.2%N/A2.4 $48.83
1/15/2022374,900 shares $18.16 million -32.7%N/A1.6 $48.44
12/31/2021556,900 shares $33.90 million +7.4%N/A1.9 $60.87
12/15/2021518,400 shares $26.85 million +5.5%N/A1.5 $51.80
11/30/2021491,300 shares $26.41 million +2.2%N/A1.4 $53.75
11/15/2021480,800 shares $29.40 million +8.4%N/A1.4 $61.14
10/29/2021443,400 shares $22.79 million +44.5%N/A1.4 $51.40
10/15/2021306,900 shares $18.20 million -33.1%N/A1 $59.29
9/30/2021458,700 shares $19.08 million +6.4%2.0%1.7 $41.59
9/15/2021431,000 shares $18.87 million -7.8%1.9%2.5 $43.78
8/31/2021467,300 shares $16.68 million +9.3%2.0%3 $35.70
8/13/2021427,600 shares $12.22 million -11.0%2.0%3.6 $28.59
7/30/2021480,200 shares $15.17 million +4.4%2.2%4.1 $31.60
7/15/2021460,200 shares $15.62 million +7.4%2.2%4.4 $33.95

BCYC Short Interest - Frequently Asked Questions

Short interest is the volume of Bicycle Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 2,883,802 shares of BCYC short. 5.36% of Bicycle Therapeutics' shares are currently sold short. Learn More on Bicycle Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCYC shares currently have a short interest ratio of 4.8. Learn More on Bicycle Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.36% of Bicycle Therapeutics' floating shares are currently sold short.

Bicycle Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 2,883,802 shares, an increase of 2.1% from the previous total of 2,825,596 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.36% of Bicycle Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bicycle Therapeutics: WAVE Life Sciences Ltd. (14.35%), Oric Pharmaceuticals, Inc. (22.65%), Olema Pharmaceuticals, Inc. (18.37%), Cullinan Therapeutics, Inc. (18.87%), Xencor, Inc. (16.35%), Sana Biotechnology, Inc. (18.64%), BioAge Labs, Inc. (10.64%), Solid Biosciences Inc. (19.06%), Vor Biopharma Inc. (14.33%), Jade Biosciences, Inc. (21.46%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling BCYC is an investing strategy that aims to generate trading profit from Bicycle Therapeutics as its price is falling. BCYC shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bicycle Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCYC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCYC, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like BCYC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:BCYC) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Buy the “unseen winner of the AI race” before July 22
Marc Chaikin - the analyst who called Nvidia before a 45,000% surge - says one overlooked AI stock could split...
Chaikin Analytics | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely, LLC | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Executive order could send gold to 6,000 per ounce
Executive Order 14330 will allow Americans to hold precious metals inside 401(k)s for the first time ever - an...
Cedar Gold Group | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
They told you not to miss this one
The largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...
Thor Metals | Sponsoredtc pixel